• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Evaluation of iron-sulfur proteins in hematopoietic cells through anamorsin

Research Project

Project/Area Number 19K08861
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 54010:Hematology and medical oncology-related
Research InstitutionOsaka University

Principal Investigator

Shibayama Hirohiko  大阪大学, 医学系研究科, 招へい教授 (60346202)

Co-Investigator(Kenkyū-buntansha) 野崎 健司  大阪大学, 医学部附属病院, 医員 (00836413)
横田 貴史  大阪大学, 医学系研究科, 准教授 (60403200)
Project Period (FY) 2019-04-01 – 2022-03-31
Project Status Completed (Fiscal Year 2021)
Budget Amount *help
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2021: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2020: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2019: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Keywordsアナモルシン / 鉄・硫黄クラスター / アポトーシス / 遺伝子欠損マウス / 条件付き遺伝子欠損マウス / Bリンパ球 / 造血幹細胞 / RNA-Seq / 鉄過剰 / 骨髄異形成症候群 / 遺伝子改変マウス
Outline of Research at the Start

アナモルシン(Anamorsin, AM)は、細胞質内の鉄・硫黄(Fe-S)クラスターを形成するのに必須の分子であることが明らかとなった。AMは、Fe-Sクラスターを有する蛋白群には必須の分子であり、AMが欠損すると、Fe-Sクラスター蛋白の機能が低下し、細胞の生存・増殖・分化などに影響を認めることを明らかにしてきた。また、AMが欠損すると細胞内に自由鉄が蓄積し、それによる活性酸素種(ROS)の蓄積、さらにアポトーシスの増加を認めるようになる。本研究では、鉄過剰状態における造血幹細胞の生存・増殖・分化の異常について、AM遺伝子改変マウスの細胞を用いることにより、AMの機能を中心に解析する。

Outline of Final Research Achievements

Anamorsin (AM) was cloned as a cell-death-defying factor. AM-deficient mice are embryonic lethal. To overcome the embryonic lethality, we generated AM conditional KO (AMflox/flox) mice. CD19-Cre/AMflox/flox mice, with AM deleted specifically in CD19+ B cells, exhibited fewer B220+ B cells in spleen, peripheral blood, and LN. CD19-Cre/AMflox/flox mice showed significantly fewer follicular type I (FO-I) cells, which are the most matured FO-B cells, and greater apoptotic cell accumulation in spleen. This suggested that AM deficiency affected terminal differentiation of B cells by increased apoptosis. Furthermore, CD19-Cre/AMflox/flox mice lacked splenic CD19+B220-/low cells. The reduction of p38MAPK, the downstream molecule of BCR signaling, in CD19-Cre/AMflox/flox mice might account for the lack of FO-I cells and splenic CD19+B220-/low cells. Overall, our results suggest that AM plays essential roles in B-cell terminal differentiation.

Academic Significance and Societal Importance of the Research Achievements

AMは鉄・硫黄(Fe-S)クラスター形成に関与する分子であることが明らかとなっている。Fe-Sクラスター蛋白は遺伝子の発現制御、DNA修復、光合成などのエネルギー代謝など様々な細胞機能に関与していることが知られているが、Fe-Sクラスター形成がB細胞の成熟分化に関連している報告はこれまでなく、今回の発見は興味深いものと考える。

Report

(4 results)
  • 2021 Annual Research Report   Final Research Report ( PDF )
  • 2020 Research-status Report
  • 2019 Research-status Report
  • Research Products

    (98 results)

All 2022 2021 2020 2019

All Journal Article (48 results) (of which Int'l Joint Research: 2 results,  Peer Reviewed: 48 results,  Open Access: 32 results) Presentation (50 results) (of which Int'l Joint Research: 14 results)

  • [Journal Article] Impaired B cell terminal differentiation in B cell-specific knockout mice of cell death-defying factor anamorsin.2022

    • Author(s)
      Hamanaka Y, Tanimura A, Yokota T, Ezoe S, Ichii M, Nagate Y, Oritani K, Kanakura Y, Hosen N, Shibayama H.
    • Journal Title

      Biochem Biophys Res Commun

      Volume: 603 Pages: 1-6

    • DOI

      10.1016/j.bbrc.2022.03.018

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Efficacy and safety of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: an open-label, single-arm, phase 2 study.2022

    • Author(s)
      Edahiro Y, Ohishi K, Gotoh A, Takenaka K, Shibayama H, Shimizu T, Usuki K, Shimoda K, Ito M, VanWart SA, Zagrijtschuk O, Qin A, Kawase H, Miyachi N, Sato T, Komatsu N, Kirito K.
    • Journal Title

      Int J Hematol

      Volume: ー Issue: 2 Pages: 215-227

    • DOI

      10.1007/s12185-022-03341-9

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Two-year outcomes of tirabrutinib monotherapy in Waldenstoom's macroglobulinemia.2022

    • Author(s)
      Sekiguchi N, Rai S, Munakata W, Suzuki K, Handa H, Shibayama H, Endo T, Terui Y, Iwaki N, Fukuhara N, Tatetsu H, Iida S, Ishikawa T, Iguchi D, Izutsu K.
    • Journal Title

      Cancer Sci

      Volume: ー Issue: 6 Pages: 2085-2096

    • DOI

      10.1111/cas.15344

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Nivolumab-induced systemic lymphadenopathy occurring during treatment of malignant melanoma: a case report.2022

    • Author(s)
      Kubo T, Hino A, Fukushima K, Shimomura Y, Kurashige M, Kusakabe S, Nagate Y, Fujita J, Yokota T, Kato H, Shibayama H, Tanemura A, Hosen N.
    • Journal Title

      Int J Hematol

      Volume: ー Issue: 2 Pages: 302-306

    • DOI

      10.1007/s12185-022-03312-0

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: 10-year follow up of the Japanese subgroup of the randomized ENESTnd trial.2022

    • Author(s)
      Nakamae H, Yamamoto M, Sakaida E, Kanda Y, Ohmine K, Ono T, Matsumura I, Ishikawa M, Aoki M, Maki A, Shibayama H.
    • Journal Title

      Int J Hematol

      Volume: 115 Issue: 1 Pages: 33-42

    • DOI

      10.1007/s12185-021-03216-5

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Significance of maintenance therapy after HDT/ASCT in symptomatic multiple myeloma: A multicenter retrospective analysis in Kansai Myeloma Forum.2021

    • Author(s)
      Nakaya A, Shibayama H, Nakatani E, Shimura Y, Kosugi S, Tanaka H, Fuchida S, Kanda J, Uoshima N, Kaneko H, Imada K, Ohta K, Ito T, Yagi H, Yoshihara S, Hino M, Shimazaki C, Takaori-Kondo A, Kuroda J, Matsumura I, Kanakura Y, Nomura S.
    • Journal Title

      eJHaem

      Volume: 2 Pages: 765-773

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] A forodesine-based regimen as a therapeutic option for PTCL-NOS with Central nervous system involvement.2021

    • Author(s)
      Doi Y, Yokota T, Shibayama H, Matsumoto K, Kurashige M, Nozaki K, Fujita J, Fukushima K, Hosen N.
    • Journal Title

      Leuk Lymphoma

      Volume: 63 Issue: 4 Pages: 1013-1015

    • DOI

      10.1080/10428194.2021.2005043

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Low-dose dasatinib in older patients with chronic myeloid leukaemia in chronic phase (DAVLEC): a single-arm, multicentre, phase 2 trial2021

    • Author(s)
      Murai K, Ureshino H, Kumagai T, Tanaka H, Nishiwaki K, Wakita S, Inokuchi K, Fukushima T, Yoshida C, Uoshima N, Kiguchi T, Mita M, Aoki J, Kimura S, Karimata K, Usuki K, Shimono J, Chinen Y, Kuroda J, Matsuda Y, Nakao K, Ono T, Fujimaki K, Shibayama H, Sakamoto J, Kimura S.
    • Journal Title

      Lancet Haematol

      Volume: 8 Issue: 12 Pages: e902-e911

    • DOI

      10.1016/s2352-3026(21)00333-1

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Carfilzomib, dexamethasone, and daratumumab in Asian patients with relapsed or refractory multiple myeloma: post hoc subgroup analysis of the phase 3 CANDOR trial.2021

    • Author(s)
      Suzuki K, Min CK, Kim K, Lee JJ, Shibayama H, Ko PS, Huang SY, Li SS, Ding B, Khurana M, Iida S.
    • Journal Title

      Int J Hematol

      Volume: 114 Issue: 6 Pages: 653-663

    • DOI

      10.1007/s12185-021-03204-9

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Phase II study of tazemetostat for relapsed or refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in Japan.2021

    • Author(s)
      Izutsu K, Ando K, Nishikori M, Shibayama H, Teshima T, Kuroda J, Kato K, Imaizumi Y, Nosaka K, Sakai R, Hojo S, Nakanishi T, Rai S.
    • Journal Title

      Cancer Sci

      Volume: 112 Issue: 9 Pages: 3627-3635

    • DOI

      10.1111/cas.15040

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Phase 2 Study of Tazemetostat for Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma with EZH2 Mutation in Japan.2021

    • Author(s)
      Izutsu K, Ando K, Nishikori M, Shibayama H, Teshima T, Kuroda J, Kato K, Imaizumi Y, Nosaka K, Sakai R, Hojo S, Nakanishi T, Rai S.
    • Journal Title

      Cancer Sci.

      Volume: 62 Issue: 7 Pages: 3627-3635

    • DOI

      10.1111/cas.14937

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Pretreatment levels of serum soluble interleukin-2 receptor are useful in selecting the treatment regimen for newly diagnosed advanced-stage follicular lymphoma with low tumor burden.2021

    • Author(s)
      Nozaki K, Sugahara H, Ueda S, Ishikawa J, Karasuno T, Iida M, Kamae T, Moriyama Y, Kawakami M, Kosugi S, Nakagawa M, Azenishi Y, Sakaniwa R, Kitamura T, Shibayama H.
    • Journal Title

      Int J Hematol

      Volume: 114 Issue: 2 Pages: 217-221

    • DOI

      10.1007/s12185-021-03151-5

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Identification of CXCL12-abundant reticular cells in human adult bone marrow2021

    • Author(s)
      Aoki K, Kurashige M, Ichii M, Higaki K, Sugiyama T, Kaito T, Ando W, Sugano N, Sakai T, Shibayama H; HANDAI Clinical Blood Club, Takaori-Kondo A, Morii E, Kanakura Y, Nagasawa T.
    • Journal Title

      Br J Haematol .

      Volume: x Issue: 3 Pages: 659-668

    • DOI

      10.1111/bjh.17396

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] High numbers of programmed cell death-1-positive tumor infiltrating lymphocytes correlate with early onset of post-transplant lymphoproliferative disorder2021

    • Author(s)
      Saito Hideaki、Miyoshi Hiroaki、Shibayama Hirohiko、Toda Jun、Kusakabe Shinsuke、Ichii Michiko、Fujita Jiro、Fukushima Kentaro、Maeda Tetsuo、Mizuki Masao、Oritani Kenji、Seto Masao、Yokota Takafumi、Kanakura Yuzuru、Hosen Naoki、Ohshima Koichi
    • Journal Title

      International Journal of Hematology

      Volume: - Issue: 1 Pages: 53-64

    • DOI

      10.1007/s12185-021-03129-3

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Oral ixazomib, lenalidomide, and dexamethasone for newly diagnosed transplant-ineligible multiple myeloma patients.2021

    • Author(s)
      Facon T, Venner CP, Bahlis NJ, Offner F, White D, Karlin L, Benboubker L, Rigaudeau S, Rodon P, Voog E, Yoon SS, Suzuki K, Shibayama H, Zhang X, Twumasi-Ankrah P, Yung G, Rifkin RM, Moreau P, Lonial S, Kumar SK, Richardson PG, Rajkumar SV.
    • Journal Title

      Blood

      Volume: 137 Issue: 26 Pages: 3616-3628

    • DOI

      10.1182/blood.2020008787

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Safety and Antitumor Activity of Acalabrutinib for Relapsed/Refractory B-cell Malignancies: A Japanese Phase I Study.2021

    • Author(s)
      Izutsu K, Ando K, Ennishi D, Shibayama H, Suzumiya J, Yamamoto K, Ichikawa S, Kato K, Kumagai K, Patel P, Iizumi S, Hayashi N, Kawasumi H, Murayama K, Nagai H.
    • Journal Title

      Cancer Sci

      Volume: 112 Issue: 6 Pages: 2405-2415

    • DOI

      10.1111/cas.14886

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Plateau is a prognostic factor of lenalidomide therapy for previously treated multiple myeloma2021

    • Author(s)
      Takakuwa Teruhito、Ohta Kensuke、Nakatani Eiji、Ito Tomoki、Kaneko Hitomi、Fuchida Shin‐Ichi、Shimura Yuji、Yagi Hideo、Shibayama Hirohiko、Kanda Junya、Uchiyama Hitoji、Kosugi Satoru、Tanaka Hirokazu、Kawata Eri、Uoshima Nobuhiko、Ishikawa Jun、Shibano Masaru、Karasuno Takahiro、Shindo Maki、Shimizu Yoshifumi、等
    • Journal Title

      Hematological Oncology

      Volume: 未定 Issue: 3 Pages: 349-357

    • DOI

      10.1002/hon.2863

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Low diversity of gut microbiota in the early phase of post-bone marrow transplantation increases the risk of chronic graft-versus-host disease.2021

    • Author(s)
      Konishi T, Kusakabe S, Hino A, Inamoto K, Yoshifuji K, Kiridoshi Y, Takeshita K, Sasajima S, Toya T, Igarashi A, Najima Y, Kobayashi T, Doki N, Motooka D, Nakamura S, Suyama M, Suda W, Shiota A, Atarashi K, Hattori M, Honda K, Yokota T, Ohashi K, Shibayama H, Fukushima K, Kakihana K.
    • Journal Title

      Bone Marrow Transplant

      Volume: 56 Issue: 7 Pages: 1728-1731

    • DOI

      10.1038/s41409-021-01249-2

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Flow cytometry analysis of peripheral Tregs in patients with multiple myeloma under lenalidomide maintenance.2021

    • Author(s)
      Nozaki K, Fujioka Y, Sugiyama D, Ishikawa J, Iida M, Shibata M, Kosugi S, Nishikawa H, Shibayama H.
    • Journal Title

      Int J Hematol

      Volume: 113 Issue: 5 Pages: 772-774

    • DOI

      10.1007/s12185-021-03093-y

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Autonomous TGFβ signaling induces phenotypic variation in human acute myeloid leukemia2021

    • Author(s)
      Yasuhiro Shingai , Takafumi Yokota,et al
    • Journal Title

      Stem cells

      Volume: - Issue: 6 Pages: 723-736

    • DOI

      10.1002/stem.3348

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Outcomes of ixazomib/lenalidomide/dexamethasone for multiple myeloma: A multicenter retrospective analysis.2021

    • Author(s)
      Takakuwa T, Yamamura R, Ohta K, Kaneko H, Imada K, Nakaya A, Fuchida SI, Shibayama H, Matsuda M, Shimazu Y, Adachi Y, Kosugi S, Uchiyama H, Tanaka H, Hanamoto H, Shimura Y, Kanda J, Onda Y, Uoshima N, Yagi H, Yoshihara S, Hino M, Shimazaki C, Takaori-Kondo A, Kuroda J, Matsumura I, Kanakura Y, Nomura S.
    • Journal Title

      Eur J Haematol

      Volume: 106 Issue: 4 Pages: 555-562

    • DOI

      10.1111/ejh.13586

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced-stage, classical Hodgkin lymphoma: a prespecified subgroup analysis of high-risk patients from the ECHELON-1 study.2021

    • Author(s)
      Hutchings M, Radford J, Ansell SM, Sureda A, Connors JM, Shibayama H, Abramson JS, Chua NS, Friedberg JW, LaCasce AS, Molina L, Engley G, Fenton K, Jolin H, Liu R, Gautam A, Gallamini A.
    • Journal Title

      Hematol Oncol

      Volume: 39 Issue: 2 Pages: 185-195

    • DOI

      10.1002/hon.2838

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Subcutaneous delivery of daratumumab in Japanese patients with relapsed/refractory multiple myeloma.2021

    • Author(s)
      Shibayama H, Matsumoto M, Kosugi H, Shibayama K, Yamazaki H, Iida S.
    • Journal Title

      Int J Hematol

      Volume: 113 Issue: 1 Pages: 112-121

    • DOI

      10.1007/s12185-020-02985-9

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Graft-versus-host disease develops in mice transplanted with lymphocyte-depleted bone marrow cells from signal-transducing adaptor protein-2 transgenic mice2021

    • Author(s)
      Saito H, Ichii M, Toda J, Kitai Y, Muromoto R, Kashiwakura JI, Saitoh K, Tanimura A, Yokota T, Shibayama H, Matsuda T, Oritani K, Kanakura Y, Hosen N.
    • Journal Title

      Biochem Biophys Res Commun .

      Volume: 537 Pages: 118-124

    • DOI

      10.1016/j.bbrc.2020.12.080

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Long-term Effects of the Janus Kinase 1/2 Inhibitor Ruxolitinib on Pulmonary Hypertension and the Cardiac Function in a Patient with Myelofibrosis2020

    • Author(s)
      Miyawaki H, Kioka H, Sato K, Kurashige M, Ozawa T, Shibayama H, Hikoso S, Morii E, Yamauchi-Takihara K, Sakata Y.
    • Journal Title

      Internal Medicine

      Volume: 59 Issue: 2 Pages: 229-233

    • DOI

      10.2169/internalmedicine.3528-19

    • NAID

      130007785096

    • ISSN
      0918-2918, 1349-7235
    • Year and Date
      2020-01-15
    • Related Report
      2019 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Ectonucleotidase CD39 is highly expressed on ATLL cells and is responsible for their immunosuppressive function.2020

    • Author(s)
      Yasuhiro Nagate, Sachiko Ezoe, Jiro Fujita, Daisuke Okuzakis, Daisuke Motooka, Tomohiko Ishibashi, Michiko Ichii, Akira Tanimura, Masako Kurashige, Eiichi Morii, Takuya Fukushima, Youko Suehiro, Takafumi Yokota, Hirohiko Shibayama, Kenji Oritani, Yuzuru Kanakura
    • Journal Title

      Leukemia

      Volume: - Issue: 1 Pages: 107-118

    • DOI

      10.1038/s41375-020-0788-y

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Signal-transducing adaptor protein-2 delays recovery of B lineage lymphocytes during hematopoietic stress2020

    • Author(s)
      Ichii Michiko、Oritani Kenji、Toda Jun、Saito Hideaki、Shi Henyun、Shibayama Hirohiko、Motooka Daisuke、Kitai Yuichi、Muromoto Ryuta、Kashiwakura Jun-ichi、Saitoh Kodai、Okuzaki Daisuke、Matsuda Tadashi、Kanakura Yuzuru
    • Journal Title

      Haematologica

      Volume: in press Issue: 2 Pages: 225573-225573

    • DOI

      10.3324/haematol.2019.225573

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Once-weekly vs. twice-weekly carfilzomib dosing in a subgroup of Japanese relapsed and refractory multiple myeloma patients from a randomized phase 3 trial (A.R.R.O.W.) and comparison with ENDEAVOR.2020

    • Author(s)
      Takezako N, Shibayama H, Handa H, Hagiwara S, Ozaki S, Suzuki K, Kosugi H, Ri M, Sugiura I, Choi I, Miyamoto T, Iida S.
    • Journal Title

      Int J Hematol

      Volume: 113 Issue: 2 Pages: 219-230

    • DOI

      10.1007/s12185-020-03013-6

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Isatuximab monotherapy in relapsed/refractory multiple myeloma: A Japanese, multicenter, Phase 1/2, safety and efficacy study.2020

    • Author(s)
      Sunami K, Suzuki K, Ri M, Matsumoto M, Shimazaki C, Asaoku H, Shibayama H, Ishizawa K, Takamatsu H, Ikeda T, Maruyama D, Kaneko H, Uchiyama M, Kiguchi T, Iyama S, Murakami H, Takahashi K, Tada K, S, Guillemin-Paveau H, Iida S.
    • Journal Title

      Cancer Sci

      Volume: 111 Issue: 12 Pages: 4526-4539

    • DOI

      10.1111/cas.14657

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Retrospective multi-center study of Adolescent and Young Adult (AYA) Multiple Myeloma in Kansai Myeloma Forum registry.2020

    • Author(s)
      Nakaya A, Kohara T, Shibayama H, Onda Y, Kanda J, Kaneko H, Kosugi S, Ishikawa J, Tanaka H, Fuchida SI, Shimura Y, Ohta K, Shimazaki C, Hino M, Takaori-Kondo A, Kuroda J, Matsumura I, Kanakura Y, Nomura S; Kansai Myeloma Forum Investigators.
    • Journal Title

      Int J Hematol

      Volume: 112 Issue: 4 Pages: 435-438

    • DOI

      10.1007/s12185-020-02996-6

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Whole-exome sequencing identified mutational profile of a case with T-cell chronic lymphocytic leukemia.2020

    • Author(s)
      Nozaki K, Yokota T, Itotagawa E, Tsutsumi K, Kusakabe S, Morikawa Y, Fujita J, Fukushima K, Maeda T, Shibayama H, Hosen N, Kumanogo A, Kanakura Y.
    • Journal Title

      Clin Case Rep

      Volume: 8 Issue: 11 Pages: 2251-2254

    • DOI

      10.1002/ccr3.3149

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Retrospective analysis of plasmacytoma in Kansai Myeloma Forum Registry.2020

    • Author(s)
      Nakaya A, Tanaka H, Yagi H, Ohta K, Shibayama H, Kohara T, Kanda J, Shindo M, Shimura Y, Kosugi S, Kaneko H, Fuchida SI, Uoshima N, Shimazaki C, Hino M, Kuroda J, Kanakura Y, Takaori-Kondo A, Nomura S, Matsumura I; Kansai Myeloma Forum Investigators.
    • Journal Title

      Int J Hematol

      Volume: 112 Issue: 5 Pages: 666-673

    • DOI

      10.1007/s12185-020-02961-3

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Signal-transducing adapter protein-1 is required for maintenance of leukemic stem cells in CML.2020

    • Author(s)
      Toda J, Ichii M, Oritani K, Shibayama H, Tanimura A, Saito H, Yokota T, Motooka D, Okuzaki D, Kitai Y, Muromoto R, Kashiwakura JI, Matsuda T, Hosen N, Kanakura Y.
    • Journal Title

      Oncogene

      Volume: 39 Issue: 34 Pages: 5601-5615

    • DOI

      10.1038/s41388-020-01387-9

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] A Multicenter, Open-Label, Phase II Study of Tirabrutinib (ONO/GS-4059) in Patients With Waldenstrom's Macroglobulinemia.2020

    • Author(s)
      Sekiguchi N, Rai S, Munakata W, Suzuki K, Handa H, Shibayama H, Endo T, Terui Y, Iwaki N, Fukuhara N, Tatetsu H, Iida S, Ishikawa T, Shiibashi R, Izutsu K.
    • Journal Title

      Cancer Sci

      Volume: 111 Issue: 9 Pages: 3327-3337

    • DOI

      10.1111/cas.14561

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Clinical utility of target capture‐based panel sequencing in hematological malignancies: A multicenter feasibility study2020

    • Author(s)
      Yasuda T, Sanada M, Nishijima D, Kanamori T, Iijima Y, Hattori H, Saito A, Miyoshi H, Ishikawa Y, Asou N, Usuki K, Hirabayashi S, Kato M, Abe M.
    • Journal Title

      Cancer Science

      Volume: 111 Issue: 9 Pages: 3367-3378

    • DOI

      10.1111/cas.14552

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] A Multi-Center Retrospective Analysis of Patients With Relapsed/Refractory Follicular Lymphoma After Third-Line Chemotherapy.2020

    • Author(s)
      Fuji S, Tada Y, Nozaki K, Saito H, Ozawa T, Kida T, Kosugi S, Sugahara H, Ikeda H, Hashimoto K, Karasuno T, Ueda S, Ishikawa J, Shibayama H.
    • Journal Title

      Ann Hematol

      Volume: 99 Issue: 9 Pages: 2133-2139

    • DOI

      10.1007/s00277-020-04126-y

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Pretreatment serum soluble interleukin-2 receptor level predicts survival in patients with newly diagnosed follicular lymphoma.2020

    • Author(s)
      Nozaki K, Sugahara H, Ueda S, Ishikawa J, Fuji S, Masaie H, Tada Y, Karasuno T, Iida M, Mitsui H, Kamae T, Saito N, Moriyama Y, Kawakami M, Kato R, Nakae Y, Kida T, Kosugi S, Nakagawa M, Uchida Y, Azenishi Y, Sakaniwa R, Kitamura T, Shibayama H.
    • Journal Title

      Leukemia and Lymphoma

      Volume: 61 Issue: 9 Pages: 2113-2121

    • DOI

      10.1080/10428194.2020.1759054

    • Related Report
      2020 Research-status Report
    • Peer Reviewed
  • [Journal Article] Limbic encephalitis with antibodies to N-methyl-D-aspartate (NMDA)-type glutamate receptor after allogeneic transplantation.2020

    • Author(s)
      Toda J, Maeda T, Akuta K, Kusakabe S, Ueda T, Fujita J, Shibayama H, Oritani K, Takahashi Y, Kanakura Y.
    • Journal Title

      Int J Hematol

      Volume: 112 Issue: 2 Pages: 254-257

    • DOI

      10.1007/s12185-020-02859-0

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Enterococcus: A predictor of ravaged microbiota and poor prognosis after allogeneic hematopoietic stem cell transplantation.2020

    • Author(s)
      Kusakabe S, Fukushima K, Yokota T, Hino A, Fujita J, Motooka D, Nakamura S, Shibayama H, Kanakura Y.
    • Journal Title

      Biol Blood Marrow Transplant

      Volume: 26 Issue: 5 Pages: 1028-1033

    • DOI

      10.1016/j.bbmt.2020.01.019

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Daratumumab, lenalidomide, and dexamethasone in Japanese patients with transplant-ineligible newly diagnosed multiple myeloma: a phase 1b study.2020

    • Author(s)
      Takamatsu H, Iida S, Shibayama H, Shibayama K, Yamazaki H, Suzuki K.
    • Journal Title

      Int J Hematol

      Volume: 115 Issue: 5 Pages: 692-701

    • DOI

      10.1007/s12185-020-02825-w

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Retreatment with brentuximab vedotin in patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large-cell lymphoma: a multicenter retrospective study.2020

    • Author(s)
      Fukuhara N, Yamamoto G, Tsujimura H, Chou T, Shibayama H, Yanai T, Shibuya K, Izutsu K.
    • Journal Title

      Leukemia and Lymphoma

      Volume: 61 Issue: 1 Pages: 176-180

    • DOI

      10.1080/10428194.2019.1654100

    • Related Report
      2019 Research-status Report
    • Peer Reviewed
  • [Journal Article] Pre- and post-serial metagenomic analysis of gut microbiota as a prognostic factor in patients undergoing haematopoietic stem cell transplantation.2020

    • Author(s)
      Kusakabe S, Fukushima K, Maeda T, Motooka D, Nakamura S, Fujita J, Yokota T, Shibayama H, Oritani K, Kanakura Y.
    • Journal Title

      Br J Haematol

      Volume: 188 Issue: 3 Pages: 438-449

    • DOI

      10.1111/bjh.16205

    • Related Report
      2019 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Treatment-free remission after first-line dasatinib discontinuation in patients with chronic myeloid leukaemia (first-line DADI trial): a single-arm, multicentre, phase 2 trial2020

    • Author(s)
      Kimura Shinya、Imagawa Jun、Murai Kazunori、Hino Masayuki、Kitawaki Toshio、Okada Masaya、Tanaka Hideo、Shindo Motohiro、Kumagai Takashi、Ikezoe Takayuki、Uoshima Nobuhiko、Sato Tsutomu、Watanabe Reiko、Kowata Shugo、Hayakawa Masaya、Hosoki Takaaki、Ikeda Kazuhiko、et al.
    • Journal Title

      The Lancet Haematology

      Volume: 7 Issue: 3 Pages: 218-225

    • DOI

      10.1016/s2352-3026(19)30235-2

    • Related Report
      2019 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Additional validation of Osaka method (0.01 mol/L dithiothreitol) for negating the daratumumab interference.2019

    • Author(s)
      Hosokawa M, Kashiwagi H, Nakayama K, Sakuragi M, Nakao M, Morikawa T, Kiyokawa T, Aochi H, Nagamine K, Shibayama H, Tomiyama Y.
    • Journal Title

      Transfusion.

      Volume: 59 Issue: 7 Pages: 2479-2480

    • DOI

      10.1111/trf.15305

    • Related Report
      2019 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Carfilzomib monotherapy in Japanese patients with relapsed or refractory multiple myeloma: A phase 1/2 study.2019

    • Author(s)
      Iida S, Watanabe T, Matsumoto M, Suzuki K, Sunami K, Ishida T, Ando K, Chou T, Ozaki S, Taniwaki M, Uike N, Shibayama H, Hatake K, Izutsu K, Ishikawa T, Shumiya Y, Tobinai K.
    • Journal Title

      Cancer Sci

      Volume: 110 Issue: 9 Pages: 2924-2932

    • DOI

      10.1111/cas.14139

    • Related Report
      2019 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Unexpected complication of R-CHOP chemotherapy: Rapidly progressive bronchiolitis obliterans syndrome.2019

    • Author(s)
      Nozaki K, Ezoe S, Hamaguchi M, Tsutsumi K, Kusakabe S, Morikawa Y, Fujita J, Fukushima K, Maeda T, Shibayama H, Kumanogo A, Kanakura Y.
    • Journal Title

      Eur J Case Rep Intern Med

      Volume: 6 Issue: 11 Pages: 001266-001266

    • DOI

      10.12890/2019_001266

    • Related Report
      2019 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Phase I study of ibrutinib in Japanese patients with treatment-naive chronic lymphocytic leukemia/small lymphocytic lymphoma.2019

    • Author(s)
      Shibayama H, Teshima T, Choi I, Hataka K, Sekiguchi N, Yoshinari N.
    • Journal Title

      J Clin Exp Hematopathology

      Volume: 59 Issue: 4 Pages: 179-186

    • DOI

      10.3960/jslrt.19023

    • NAID

      130007771350

    • Related Report
      2019 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Endothelial Cell-Selective Adhesion Molecule Contributes to the Development of Definitive Hematopoiesis in the Fetal Liver2019

    • Author(s)
      Ueda Tomoaki、Yokota Takafumi、Okuzaki Daisuke、Uno Yoshihiro、Mashimo Tomoji、Kubota Yoshiaki、Sudo Takao、Ishibashi Tomohiko、Shingai Yasuhiro、Doi Yukiko、Ozawa Takayuki、Nakai Ritsuko、Tanimura Akira、Ichii Michiko、Ezoe Sachiko、Shibayama Hirohiko、Oritani Kenji、Kanakura Yuzuru
    • Journal Title

      Stem Cell Reports

      Volume: 13 Issue: 6 Pages: 992-1005

    • DOI

      10.1016/j.stemcr.2019.11.002

    • Related Report
      2019 Research-status Report
    • Peer Reviewed / Open Access
  • [Presentation] Clinical Significance of FLT3 Mutations in a Comprehensive NGS Multicenter Study of AML: HM-Screen-Japan 012021

    • Author(s)
      Kentaro Fukushima, Hirohiko Shibayama, SungGi Chi, Naoko Hosono, Takahiro Yamauchi, Seiichiro Katagiri, Akihiko Gotoh, Makoto Yoshimitsu, Kenji Ishitsuka, Takaaki Ono, Naoto Takahashi, Satoshi Iyama, Makoto Nakamura, Yukinori Nakamura, Suguru Fukuhara, Koji Izutsu, Nobuhiko Yamauchi, Junichiro Yuda, Yosuke Minami
    • Organizer
      The American Society of Hematology 63rd Annual Meeting
    • Related Report
      2021 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Very Low-Dose Dasatinib Is a Safe and Effective Therapy for Elderly Patients with Newly-Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Results from the Davlec Study, a Single-Arm, Multicenter, Phase 2 Trial2021

    • Author(s)
      Takashi Kumagai, Kazunori Murai, Hiroshi Ureshino, Hideo Tanaka, Takaaki Ono, Katsumichi Fujimaki, Hirohiko Shibayama, Chisaki Mizumoto, Tomoharu Takeoka, Katsuhiro Io, Takeshi Kondo, Masatomo Miura, Yosuke Minami, Takayuki Ikezoe, Jun Imagawa, Ayako Takamori, Atsushi Kawaguchi, Junichi Sakamoto, Shinya Kimura
    • Organizer
      The American Society of Hematology 63rd Annual Meeting
    • Related Report
      2021 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Two-year follow-up data of Phase II study of Tirabrutinib, a second-generation bruton’s tyrosine kinase inhibitor, in patients with treatment-naive or relapsed/refractory Waldenstrom’s macroglobulinemia.2021

    • Author(s)
      Kenshi Suzuki, Naohiro Sekiguchi, Shinya Rai, Wataru Munakata, Hiroshi Handa, Hirohiko Shibayama, Tomoyuki Endo, Yasuhito Terui, Noriko Iwaki, Noriko Fukuhara, Hiro Tatetsu, Shinsuke Iida, Takayuki Ishikawa, Daisuke Iguchi, Koji Izutsu
    • Organizer
      The American Society of Hematology 63rd Annual Meeting
    • Related Report
      2021 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Late vs Early Response and Depth of Response Are Associated with Improved Outcomes in Newly Diagnosed Multiple Myeloma (NDMM) Patients (pts) Treated with Ixazomib-Lenalidomide-Dexamethasone (IRd) or Placebo-Lenalidomide-Dexamethasone (pbo-Rd) in the Phase 3 TOURMALINE-MM2 Trial2021

    • Author(s)
      Paul G. Richardson, Thierry Facon, Sophie Rigaudeau, Eric Voog, Sung-Soo Yoon, Kenshi Suzuki, Hirohiko Shibayama, Xiaoquan Zhang, Arun Kumar, Philip Twumasi-Ankrah, Richard Labotka, Robert M. Rifkin, Sagar Lonial, Shaji K Kumar, S. Vincent Rajkumar, Philippe Moreau
    • Organizer
      The American Society of Hematology 63rd Annual Meeting
    • Related Report
      2021 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Genomic analysis of TP53 mutations in a multicenter NGS study of AML: HM-SCREEN-Japan01.2021

    • Author(s)
      Kentaro Fukushima, SunGi Chi, Hirohiko Shibayama, Nohoko Hosono, Takahiro Yamauchi, Seiichiro Katagiri, Akihiko Gotoh, Naoto Takahashi, Satoshi Iyama, Makoto Nakamura, Yukinobu Nakamura, Suguru Fukuhara, Koji Izutsu, Hirohiko Yamauchi, Junichiro Yuda, Yosuke Minami
    • Organizer
      第83回日本血液学会学術集会
    • Related Report
      2021 Annual Research Report
  • [Presentation] Very elderly patients with myeloma: a multicenter retrospective analysis from Kansai Myeloma forum.2021

    • Author(s)
      Yusuke Okayama, Teruhito Takakuwa, Yuji Shimura, Nobuhiko Uoshima, Satoshi Yoshihara, Junya Kanda, Hirohiko Shibayama, Kentaro Fukushima, Kensuke Ota, Hideo Yagi, Shosaku Nomura, Chihiro Shimazaki, Itaru Matsumura, Akifumi Takaori, Naoki Hosen, Masayuki Hino, Junya Kuroda
    • Organizer
      第83回日本血液学会学術集会
    • Related Report
      2021 Annual Research Report
  • [Presentation] Nobel web application predicting patient-specific prognosis in MM from KMF using machine learning.2021

    • Author(s)
      Teruhito Takakuwa, Hiroshi Okamura, Shin-ichi Fuchida, Yuji Shimura, Junya Kanda, Nobuhiko Uoshima, Hirohiko Shibayama, Satoshi Yoshihara, Hideo Yagi, Masayuki Hino, Yuzuru Kanakura, Junya Kuroda, Akifumi Takaori, Chihiro Shimazaki, Itaru Matsumura, Shosaku Nomura
    • Organizer
      第83回日本血液学会学術集会
    • Related Report
      2021 Annual Research Report
  • [Presentation] Efficacy of elotuzumab plus lenalidomide and dexamethasone for MM: A retrospective analysis from KMF.2021

    • Author(s)
      Shin-ichi Fuchida, Tomoki Ito, Kensuke Ota, Hirohiko Shibayama, Kentaro Fukushima, Hirokazu Tanaka, Yuji Shimura, Kazunori Imada, Hideo Yagi, Satoshi Yoshihara, Masayuki Hino, Naoki Hosen, Akifumi Takaori, Itaru Matsumura, Shosaku Nomura, Chihiro Shimazaki, Junya Kuroda
    • Organizer
      第83回日本血液学会学術集会
    • Related Report
      2021 Annual Research Report
  • [Presentation] Using ImmunoFISH to determine lymphoid neoplasm relapse after sex-mismatched HSCT or PTLD occurrence2021

    • Author(s)
      Ryumei Kurashige, Masako Kurashige, Yosuke Okada, Kohei Higuchi, Akihisa Hino, Takako Miyamura, Michiko Ichii, Kentaro Fukushima, Makoto Takeuchi, Akihisa Sawada, Masami Inoue, Hirohiko Shibayama, Eiichi Morii, Naoki Hosen
    • Organizer
      第83回日本血液学会学術集会
    • Related Report
      2021 Annual Research Report
  • [Presentation] A Phase 2b study of an oral HDAC inhibitor HBI-8000 in patients with relapsed or refractory ATL2021

    • Author(s)
      Tatsuro Jo, Atae Utsunomiya, Koji Izutsu, Hirohiko Shibayama, Kazuya Shimoda, Yasushi Takamatsu, Kuniko Takano, Kunihiro Tsukasaki, Jun Taguchi, Kentaro Yonekura, Shinichi Makita, Mireille Gillings, Hiroshi Onogi, Kensei Tobinai
    • Organizer
      第83回日本血液学会学術集会
    • Related Report
      2021 Annual Research Report
  • [Presentation] Genomic analysis of relapsed AML with RUNX1-RUNX1T1 in a comprehensive NGS multicenter study of AML2021

    • Author(s)
      Seiichiro Katagiri, Daigo Akabane, Akihiko Gotoh, SunGi Chi, Kentaro Fukushima, Hirohiko Shibayama, Naoko Hosono, Takahiro Yamauchi, Naoto Takahashi, Satoshi Iyama, Makoto Nakamura, Yukinobu Nakamura, Koji Izutsu, Hirohiko Yamauchi, Junichiro Yuda, Yosuke Minami
    • Organizer
      第83回日本血液学会学術集会
    • Related Report
      2021 Annual Research Report
  • [Presentation] Genetic features of AML with MLL-rearrangement and NPM1 mutation: HM-SCREEN-JAPAN012021

    • Author(s)
      SunGi Chi, Kentaro Fukushima, Hirohiko Shibayama, Naoko Hosono, Takahiro Yamauchi, Seiichiro Katagiri, Akihiko Gotoh, Naoto Takahashi, Satoshi Iyama, Makoto Nakamura, Yukinobu Nakamura, Suguru Fukuhara, Koji Izutsu, Hirohiko Yamauchi, Junichiro Yuda, Yosuke Minami
    • Organizer
      第83回日本血液学会学術集会
    • Related Report
      2021 Annual Research Report
  • [Presentation] Genetic features of AML with normal karyotype: HM-SCREEN-JAPAN012021

    • Author(s)
      SunGi Chi, Masamitsu Yanada, Kazuhito Yamamoto, Naoko Hosono, Takahiro Yamauchi, Kentaro Fukushima, Hirohiko Shibayama, Seiichiro Katagiri, Akihiko Gotoh, Naoto Takahashi, Satoshi Iyama, Makoto Nakamura, Yukinobu Nakamura, Suguru Fukuhara, Koji Izutsu, Hirohiko Yamauchi, Junichiro Yuda, Yosuke Minami
    • Organizer
      第83回日本血液学会学術集会
    • Related Report
      2021 Annual Research Report
  • [Presentation] Genetic features of AML with IDH1/IDH2 mutation: HM-SCREEN-JAPAN012021

    • Author(s)
      Hirotaka Nakamura, SunGi Chi, Kentaro Fukushima, Hirohiko Shibayama, Naoko Hosono, Takahiro Yamauchi, Seiichiro Katagiri, Akihiko Gotoh, Naoto Takahashi, Satoshi Iyama, Makoto Nakamura, Yukinobu Nakamura, Suguru Fukuhara, Koji Izutsu, Hirohiko Yamauchi, Junichiro Yuda, Yosuke Minami
    • Organizer
      第83回日本血液学会学術集会
    • Related Report
      2021 Annual Research Report
  • [Presentation] A mutation profiling multicenter study of patients with AML: HM-SCREEN-JAPAN012021

    • Author(s)
      Naoko Hosono, Takahiro Yamauchi, SunGi Chi, Kentaro Fukushima, Hirohiko Shibayama, Seiichiro Katagiri, Akihiko Gotoh, Naoto Takahashi, Satoshi Iyama, Makoto Nakamura, Yukinobu Nakamura, Suguru Fukuhara, Koji Izutsu, Hirohiko Yamauchi, Junichiro Yuda, Yosuke Minami
    • Organizer
      第83回日本血液学会学術集会
    • Related Report
      2021 Annual Research Report
  • [Presentation] A case of PTCL-NOS with central nervous system involvement successfully treated with oral forodesine.2021

    • Author(s)
      Yukio Doi, Takafumi Yokota, Hirohiko Shibayama, Kana Matsumoto, Masako Kurashige, Kenji Nozaki, Kouki Yoshida, Makiko Suga, Midori Koike, Jun Toda, Keigo Akuta, Akihisa Hino, Tomoaki Ueda, Yasuhiro Nagate, Jiro Fujita, Kentaro Fukushima, Naoki Hosen
    • Organizer
      第83回日本血液学会学術集会
    • Related Report
      2021 Annual Research Report
  • [Presentation] A Phase 2b study of an oral HDAC inhibitor HBI-8000 in patients with relapsed or refractory PTCL2021

    • Author(s)
      Hidetsugu Kawai, Jun Ando, Ilseung Choi, Junya Kuroda, Mitsutoshi Kurosawa, Hong Ghi Lee, Jae Hoon Lee, Won Sik Lee, Hironobu Minami, Hirokazu Nagai, Hirohiko Shibayama, Takeo Shindo, Kenji Tsukamoto, Kunihiro Tsukasaki, Toshiki Uchida, Shinya Rai, Deok Hwan Yang, Shinichiro Yoshida, Mireille Gillings, Kensei Tobinai
    • Organizer
      第83回日本血液学会学術集会
    • Related Report
      2021 Annual Research Report
  • [Presentation] Genetic features of AML requiring hematopoietic stem cell transplantation: HM-SCREEN-JAPAN012021

    • Author(s)
      Motoki Eguchi, Takanobu Morishita, SunGi Chi, Kentaro Fukushima, Hirohiko Shibayama, Naoko Hosono, Takahiro Yamauchi, Seiichiro Katagiri, Akihiko Gotoh, Naoto Takahashi, Satoshi Iyama, Makoto Nakamura, Yukinobu Nakamura, Suguru Fukuhara, Koji Izutsu, Hirohiko Yamauchi, Junichiro Yuda, Yosuke Minami
    • Organizer
      第83回日本血液学会学術集会
    • Related Report
      2021 Annual Research Report
  • [Presentation] Clinical significance of FLT3 mutations in a NGS multicenter study of AML: HM-SCREEN-JAPAN012021

    • Author(s)
      Kentaro Fukushima, Hirohiko Shibayama, SunGi Chi, Nohoko Hosono, Takahiro Yamauchi, Seiichiro Katagiri, Akihiko Gotoh, Naoto Takahashi, Satoshi Iyama, Makoto Nakamura, Yukinobu Nakamura, Suguru Fukuhara, Koji Izutsu, Hirohiko Yamauchi, Junichiro Yuda, Yosuke Minami
    • Organizer
      第83回日本血液学会学術集会
    • Related Report
      2021 Annual Research Report
  • [Presentation] Genomic Analysis of FLT3 Mutations in a Comprehensive NGS Multicenter Study of AML: HM-Screen-Japan 01.2020

    • Author(s)
      Kentaro Fukushima, SungGi Chi, , Hirohiko Shibayama, , Naoko Hosono, Kenichi Miyamoto, Yosuke Minami
    • Organizer
      The American Society of Hematology 62nd Annual Meeting
    • Related Report
      2020 Research-status Report
    • Int'l Joint Research
  • [Presentation] ASXL1 Mutations Predict a Poor Response to Darbepoetin Alfa in Anemic Patients with Low-Risk MDS: A Multicenter, Phase II Study.2020

    • Author(s)
      Hitoshi Hanamoto, Yasuyoshi Morita, Motoshi Ichikawa, Yasuhito Nannya, Hirohiko Shibayama, Yoshinobu Maeda, Tomoko Hata, Toshihiro Miyamoto, Hiroshi Kawabata, Kazuto Takeuchi, Hiroko Tanaka, Junji Kishimoto, Satoru Miyano, Itaru Matsumura, Seishi Ogawa, Koichi Akashi, Yuzuru Kanakura, Kinuko Mitani
    • Organizer
      The American Society of Hematology 62nd Annual Meeting
    • Related Report
      2020 Research-status Report
    • Int'l Joint Research
  • [Presentation] The Phase 3 TOURMALINE-MM2 Trial: Oral Ixazomib, Lenalidomide, and Dexamethasone (IRd) Vs Placebo-Rd for Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma (NDMM).2020

    • Author(s)
      Thierry Facon, Christopher P. Nizar Bahlis, Fritz Offner, Darrell J White, Lotfi Benboubker, Sophie Rigaudeau, Philippe Rodon, Sung-Soo Yoon, Kenshi Suzuki, Hirohiko Shibayama, Xiaoquan Zhang, Godwin Yung, Robert M. Rifkin, Philippe Moreau, Sagar Lonial, Shaji K. Kumar, Paul G. Richardson, Vincent Rajkumar
    • Organizer
      The American Society of Hematology 62nd Annual Meeting
    • Related Report
      2020 Research-status Report
    • Int'l Joint Research
  • [Presentation] Polatuzumab vedotin with bendamustine and rituximab in r/ r DLBCL (P-DRIVE): A phase 2 study in Japan2020

    • Author(s)
      Hirohiko Shibayama,Shinya Rai,Koji Izutsu,Motoko Yamaguchi, Jun Takizawa,Misato Hashizume,Yasuhito Terui
    • Organizer
      第82回日本血液学会学術集会
    • Related Report
      2020 Research-status Report
  • [Presentation] ASXL1 mutations predict a poor response to darbepoetin alfa in anemic patients with low-risk MDS2020

    • Author(s)
      Hirohiko Shibayama, Yasuyoshi Morita, Motoshi Ichikawa, Yasuhito Nannya, Hitoshi Hanamoto, Yoshinobu Maeda, Tomoko Hata, Toshihiro Miyamoto, Hiroshi Kawabata,Kazuto Takeuchi,Hiroko Tanaka,Junji Kishimoto,Satoru Miyano,Itaru Matsumura,Seishi Ogawa, Koichi Akashi, Yuzuru Kanakura, Kinuko Mitani
    • Organizer
      第82回日本血液学会学術集会
    • Related Report
      2020 Research-status Report
  • [Presentation] Patient demographics in a prospective observational study of plasma cell neoplasms in Japan2020

    • Author(s)
      Hirohiko Shibayama,Mitsuhiro Itagaki,Hiroshi Handa,Akihiro Yokoyama,Morio Sawamura,Toshiki Saito,Itaru Matsumura,Koichi Akashi,Shinsuke Iida
    • Organizer
      第82回日本血液学会学術集会
    • Related Report
      2020 Research-status Report
  • [Presentation] A multi-center retrospective analysis of relapsed/refractory FL after 3rd-line chemotherapy2020

    • Author(s)
      Shigeo Fuji,Yuma Tada,Kenji Nozaki,Hideaki Saito, Takayuki Ozawa,Toru Kida,Satoru Kosugi,Hiroyuki Sugahara, Hirokazu Ikeda,Koji Hashimoto,Takahiro Karasuno,Shuji Ueda,Jun Ishikawa,Hirohiko Shibayama
    • Organizer
      第82回日本血液学会学術集会
    • Related Report
      2020 Research-status Report
  • [Presentation] Multi-color analysis of immune response of myeloma patients under lenalidomide maintenance2020

    • Author(s)
      Kenji Nozaki,Yuki Fujioka,Jun Ishikawa,Masato Iida,Masaru Shibata,Satoru Kosugi,Hirohiko Shibayama
    • Organizer
      第82回日本血液学会学術集会
    • Related Report
      2020 Research-status Report
  • [Presentation] Induction therapies for transplant-ineligible NDMM: retrospective analysis of 547 cases from KMF2020

    • Author(s)
      Yuji Shimura,Hirohiko Shibayama,Aya Nakaya,Ryosuke Yamamura,Kazunori Imada,Masayuki Hino,Akifumi Takaori,Itaru Matsumura,Yuzuru Kanakura,Shosaku Nomura
    • Organizer
      第82回日本血液学会学術集会
    • Related Report
      2020 Research-status Report
  • [Presentation] Daratumumab/Len/Dex (D-Rd) in non-transplant NDMM: Update of MMY1006 (Japanese patients) and MAIA2020

    • Author(s)
      Saad Z. Usmani,Hirohiko Shibayama,Kenshi Suzuki,Shinsuke Iida,Thierry Facon,Nizar J. Bahlis,Hiroshi Yamazaki,Jianping Wang,Rian Van Rampelbergh,Hiroyuki Takamatsu
    • Organizer
      第82回日本血液学会学術集会
    • Related Report
      2020 Research-status Report
  • [Presentation] Subanalysis of FLT3 mutations in comprehensive NGS multicenter study of AML: HM-SCREEN-Japan 012020

    • Author(s)
      Kentaro Fukushima, Hirohiko Shibayama, Kenichi Miyamoto, Naoko Hosono, Takahiro Yamauchi, Nobuhiko Yamauchi, Yosuke Minami
    • Organizer
      第82回日本血液学会学術集会
    • Related Report
      2020 Research-status Report
  • [Presentation] PET-CT after bendamustine + rituximab for follicular lymphoma in first relapse can predict PFS2020

    • Author(s)
      Miyuki Okura,Koji Kato,Junji Suzumiya,Koji Izutsu,Momoko Nishikori, Hirohiko Shibayama,Yoshinobu Maeda,Kenichi Yoshimura,Ukihide Tateishi,Toshihiro Miyamoto,Jun Ishikawa,Shinya Rai,Tsutomu Takahashi,Koichi Akashi,Yuzuru Kanakura
    • Organizer
      第82回日本血液学会学術集会
    • Related Report
      2020 Research-status Report
  • [Presentation] Carfilzomib and dexamethasone (Kd) with/without daratumumab (D): subgroup analysis in Asian patients2020

    • Author(s)
      Kenshi Suzuki,Chang-Ki Min,Kihyun Kim,Je-Jung Lee,Hirohiko Shibayama,Po-Shen Ko,Shang-Yi Huang,Sin-Syue Li,Bifeng Ding,Monica Khurana,Seasea Gao,Shinsuke Iida
    • Organizer
      第82回日本血液学会学術集会
    • Related Report
      2020 Research-status Report
  • [Presentation] A phase 1 study of acalabrutinib in Japanese patients with B-cell malignancies2020

    • Author(s)
      Hirokazu Nagai,Kiyoshi Ando,Daisuke Ennishi,Hirohiko Shibayama,Junji Suzumiya,Kazuhito Yamamoto,Satoshi Ichikawa,Koji Kato,Kyoya Kumagai,Priti Patel,Sakura Iizumi,Nobuya Hayashi,Hisashi Kawasumi,Koji Izutsu
    • Organizer
      第82回日本血液学会学術集会
    • Related Report
      2020 Research-status Report
  • [Presentation] Autonomous TGFβ signaling promotes phenotypic variations of human AML cells2020

    • Author(s)
      Yasuhiro Shingai,Takafumi Yokota,Ritsuko Nakai,Takayuki Ozawa, Tomoaki Ueda,Yukiko Doi,Tomohiko Ishibashi,Michiko Ichii, Hirohiko Shibayama,Yuzuru Kanakura,Naoki Hosen
    • Organizer
      第82回日本血液学会学術集会
    • Related Report
      2020 Research-status Report
  • [Presentation] Special AT-rich sequence binding protein 1 induces antigen presenting function in splenic B cells2020

    • Author(s)
      Takayuki Ozawa, Takafumi Yokota, Ritsuko Nakai, Yasuhiro Shingai, Tomoaki Ueda, Yukiko Doi, Hirohiko Shibayama, Naoki Hosen
    • Organizer
      第82回日本血液学会学術集会
    • Related Report
      2020 Research-status Report
  • [Presentation] A Novel UniFrac-Based Analytical Method for Determining Sequential Changes in Gut Microbiota After Hematopoietic Stem Cell Transplantation.2019

    • Author(s)
      Shinsuke Kusakabe, Kentaro Fukushima, Takafumi Yokota, Jiro Fujita, Daisuke Motooka, Shota Nakamura, Hirohiko Shibayama, Yuzuru Kanakura
    • Organizer
      The 10th JSH International Symposium
    • Related Report
      2019 Research-status Report
    • Int'l Joint Research
  • [Presentation] Special AT-Rich Sequence Binding Protein 1 Is Involved In the Formation of Germinal Center B Cells in the Murine Spleen.2019

    • Author(s)
      Ozawa T, Yokota T, Shingai Y, Ueda T, Doi Y, Shibayama H, Kanakura Y
    • Organizer
      The 10th JSH International Symposium
    • Related Report
      2019 Research-status Report
    • Int'l Joint Research
  • [Presentation] ENTEROCOCCUS-PREDOMINANT INTESTINAL MICROBIOTA INDICATES POOR PROGNOSIS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION.2019

    • Author(s)
      Shinsuke Kusakabe, Kentaro Fukushima, Takafumi Yokota, Ritsuko Nakai, Akihisa Hino, Yasuhiro Nagate, Yukiko Doi, Jiro Fujita, Daisuke Motooka, Shota Nakamura, Hirohiko Shibayama, Yuzuru Kanakura
    • Organizer
      The 24th European Hematology Association
    • Related Report
      2019 Research-status Report
    • Int'l Joint Research
  • [Presentation] Special AT-rich Sequence Binding Protein 1 (SATB1) is markedly expressed in the Dark Zone Germinal Center B Cells on Murine Spleen.2019

    • Author(s)
      Ozawa T, Yokota T, Shingai Y, Ueda T, Doi Y, Shibayama H, Kanakura Y
    • Organizer
      The 24th European Hematology Association
    • Related Report
      2019 Research-status Report
    • Int'l Joint Research
  • [Presentation] The influence of tumor immune microenvironment and tumor immunity on the pathogenesis, treatment and prognosis of post-transplant lymphoproliferative disorders (PTLD).2019

    • Author(s)
      Hideaki Saito, Hirohiko Shibayama, Hiroaki Miyoshi, Jun Toda, Shinsuke Kusakabe, Michiko Ichii, Jiro Fujita, Kentaro Fukushima, Takafumi Yokota, Tetsuo Maeda, Maso Mizuki, Kenji Oritani, Masao Seto, Koichi Ohshima, Yuzuru Kanakura
    • Organizer
      15th International Conference on Malignant Lymphoma
    • Related Report
      2019 Research-status Report
    • Int'l Joint Research
  • [Presentation] Elevated serum soluble interleukin-2 receptor level is a useful prognostic factor for disease-specific overall survival in patients with newly diagnosed follicular lymphoma before initiation of treatment.2019

    • Author(s)
      Nozaki K, Sugahara H, Ueda S, Ishikawa J, Fuji S, Masaie H, Tada Y, Suga M, Tsutsumi K, Shibata K, Kida S, Karasuno, T Sata H, Yasumi,5 Masato Iida M, Mitsui H,Kamae T, Saito, N Murakami H, Moriyama Y, Kawakami M,Kato R, Nakae Y,Kida T, Kosugi S, Nakagawa, M Uchida Y, Azenishi Y, Sakaniwa R, Kitamura T, Shibayama H
    • Organizer
      The American Society of Hematology 61th Annual Meeting
    • Related Report
      2019 Research-status Report
    • Int'l Joint Research
  • [Presentation] Phase 2 Study of Tirabrutinib (ONO/GS-4059), a Second-Generation Bruton’s Tyrosine Kinase Inhibitor, Monotherapy in Patients with Treatment-Naive or Relapsed/Refractory Waldenstrom Macroglobulinemia.2019

    • Author(s)
      Wataru Munakata, Naohiro Sekiguchi, Rai Shinya, Kenshi Suzuki, Hiroshi Handa, Hirohiko Shibayama, Tomoyuki Endo, Yasuhito Terui, Noriko Iwaki, Noriko Fukuhara, Hiro Tatetsu, Shinsuke Iida, Takayuki Ishikawa, Ryota Shiibashi, Koji Izutsu
    • Organizer
      The American Society of Hematology 61th Annual Meeting
    • Related Report
      2019 Research-status Report
    • Int'l Joint Research
  • [Presentation] Fatal fungemia caused by Exophiala genus in two patients after allogeneic stem cell transplantation.2019

    • Author(s)
      Nakai R, Fukushima K, Hino A, Kusakabe S, Nagate Y, Fujita J, Yokota T, Shibayama H, Kanakura Y.
    • Organizer
      第41回 造血細胞移植学会
    • Related Report
      2019 Research-status Report
  • [Presentation] A young male immunocompetent patient of atypical CD56- EBER1- extraosseous plasmacytoma with plasmablastic morphology.2019

    • Author(s)
      Nakai R, Ueda Y, Wada N, Hino A, Kusakabe S, Nagate Y, Doi Y, Fujita J, Fukushima K, Yokota T, Shibayama H, Morii E, Kanakura Y.
    • Organizer
      第59回 リンパ網内系学会
    • Related Report
      2019 Research-status Report
  • [Presentation] Contributions of high number of PD-1+ tumor infiltrating lymphocytes to early onset of PTLD.2019

    • Author(s)
      Hideaki Saito, Hiroaki Miyoshi, Hirohiko Shibayama, Jun Toda, Shinsuke Kusakabe, Michiko Ichii, Jiro Fujita, Kentaro Fukushima, Tetsuo Maeda, Masao Mizuki, Kenji Oritani, Masao Seto, Takafumi Yokota, Yuzuru Kanakura, and Koichi Ohshima
    • Organizer
      第81回日本血液学会学術集会
    • Related Report
      2019 Research-status Report
  • [Presentation] Special AT-Rich Sequence Binding Protein 1 Is Involved In the Formation of splenic B Cells.2019

    • Author(s)
      Ozawa T, Yokota T, Shingai Y, Ueda T, Doi Y, Shibayama H, Kanakura Y
    • Organizer
      第81回日本血液学会学術集会
    • Related Report
      2019 Research-status Report
  • [Presentation] 抗CD38 抗体isatuximab単剤による日本人の再発難治多発性骨髄腫患者を対象とした第1/2相試験2019

    • Author(s)
      李 政樹, 角南一貴, 松本守生, 島崎千尋, 麻奥英毅, 丸山 大, 柴山浩彦, 石澤 賢一, 高松博幸, 池田宇次, 金子仁臣, 内山倫宏, 木口 亨, 井山 諭, 村上博和, 佐々木 亨, 多田圭佑, 鈴木憲史, 飯田真介
    • Organizer
      第81回日本血液学会学術集会
    • Related Report
      2019 Research-status Report
  • [Presentation] 実臨床におけるイキサゾミブの治療成績:関西ミエローマフォーラムのデータベースによる多施設後方視的解析2019

    • Author(s)
      高桑輝人, 山村亮介, 太田健介, 金子仁臣, 今田和典, 中谷 綾, 淵田真一, 柴山浩彦, 松田光弘, 島津 裕, 足立陽子, 小杉 智, 内山人二, 田中宏和, 花本 仁, 志村勇司, 諫田淳也, 恩田佳幸, 魚嶋伸彦, 八木秀男, 吉原 哲, 日野雅之, 島崎千尋, 高折晃史, 黒田純也, 松村 到, 金倉 譲, 野村昌作
    • Organizer
      第81回日本血液学会学術集会
    • Related Report
      2019 Research-status Report
  • [Presentation] 多発性骨髄腫におけるクリニカルシークエンスの実行可能性の研究2019

    • Author(s)
      李 政樹, 安田貴彦, 半田 寛, 石田禎夫, 柴山浩彦, 安倍正博, 金森貴之, 真田 昌, 服部浩佳, 西島 大, 倉橋浩樹, 白石友一, 山本松雄, 齋藤明子, 宮野 悟, 小川誠司, 堀部敬三, 飯田真介
    • Organizer
      第81回日本血液学会学術集会
    • Related Report
      2019 Research-status Report
  • [Presentation] 末梢性T細胞リンパ腫の多施設共同後方視的研究:自家移植と予後との関連性2019

    • Author(s)
      多田雄真, 藤 重夫, 政家寛明, 吉田 均, 小杉 智, 菅原浩之, 上田周二, 柴山浩彦, 石川 淳, 金倉 譲
    • Organizer
      第81回日本血液学会学術集会
    • Related Report
      2019 Research-status Report

URL: 

Published: 2019-04-18   Modified: 2023-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi